dt 5461 has been researched along with Fibrosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akimoto, T; Jimbo, T; Joto, N; Kumazawa, E; Tohgo, A | 2 |
2 other study(ies) available for dt 5461 and Fibrosarcoma
Article | Year |
---|---|
Antitumor effect of DT-5461a, a synthetic low-toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation.
Topics: Animals; Antineoplastic Agents; Carbohydrate Sequence; Cytotoxicity Tests, Immunologic; Disaccharides; Fibrosarcoma; Lipid A; Macrophage Activation; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasm Transplantation; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
Antitumor effect of DT-5461, a lipid A derivative, against human tumor xenografts is mediated by intratumoral production of tumor necrosis factor and affected by host immunosuppressive factors in nude mice.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Dinoprostone; Disaccharides; Drug Screening Assays, Antitumor; Fibrosarcoma; Humans; Lipid A; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |